# Sugar Based Excipients Market > Sugar Based Excipients Market Research Report: Size, Share, Trend Analysis By Types (Disintegrants, Binders, Fillers, Sweeteners), By Applications (Tablets, Capsules, Oral Liquids, Injectables), By Dosage Form (Solid Dosage Forms, Liquid Dosage Forms, Semi-Solid Dosage Forms), By End Users (Pharmaceutical Industry, Food and Beverage Industry, Cosmetics and Personal Care Industry) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.38% - **2024:** $ 1.29 Billion - **2025:** $ 1.37 Billion - **2035:** $ 2.55 Billion - **Key Players:** Roquette Freres (FR), Ashland Global Holdings Inc. (US), BASF SE (DE), DuPont de Nemours Inc. (US), MannKind Corporation (US), DOW Chemical Company (US), Cargill Inc. (US), FMC Corporation (US) **Report ID:** MRFR/HC/25777-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/sugar-based-excipients-market-27451 --- ## Market Summary ## **Sugar Based Excipients Market Overview:** As per MRFR analysis, the Sugar-Based Excipients Market Size was estimated at 1.19 (USD Billion) in 2023. The Sugar-Based Excipients Market Industry is expected to grow from 1.29 (USD Billion) in 2024 to 2.24 (USD Billion) by 2032. The Market CAGR (growth rate) is expected to be around 6.38% during the forecast period (2024 - 2032). ### **Key Sugar Based Excipients Market Trends Highlighted** The global sugar-based excipients market is experiencing a surge in demand, driven by the pharmaceutical industry's increasing focus on patient safety and cost-effectiveness. These excipients, derived from natural sugars like sucrose, lactose, and starch, play a crucial role in formulating tablets, capsules, and other dosage forms. The market is particularly driven by the growing demand for sugar-based excipients in the production of oral solid dosage forms, which account for the majority of drug delivery systems. Additionally, the rising prevalence of chronic diseases is fueling the demand for sugar-based excipients in controlled-release formulations. The industry is also witnessing a shift towards excipients that offer enhanced functionality, such as improved solubility, bioavailability, and compressibility. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **Sugar Based Excipients Market Drivers** ### **Increased Demand for Sugar-Based Excipients in Pharmaceutical Applications** Good morning. The pharmaceuticals sector is involved in the production of medicine and has been one of the sectors experiencing substantial growth, especially in emerging markets, over the past decades. Sugar-based excipients are essential to the production of medications as they can enhance the stability and solubility of an API to different degrees. It is expected that the continued expansion of the pharmaceutical industry will drive the demand for sugar-based excipients in the short and long term.Additionally, new opportunities will be created in the pharmaceutical sector as new drugs that use novel drug delivery systems are developed. Thank you. ### **Rising Prevalence of Chronic Diseases and the Need for Effective Drug Delivery** One of the main factors fueling the growth of the Sugar Based Excipients Market Industry is the rising incidence of chronic diseases, including diabetes, cardiovascular diseases and cancer. As these diseases are of a chronic nature, their treatment requires a long-term medication regime. Moreover, medications used to treat most of these diseases are multicomponent formulations, which need to be stable, available in a form that ensures bioavailability of all components, and safely released to target organs.All these characteristics are fulfilled by the use of sugar-based excipients. This is evident from the fact that the growing prevalence of chronic diseases is expected to result in an increase in demand for medicines, which in turn will promote the growth of the sugar excipients market. ### **Technological Advancements and Innovation in Drug Formulation** Advancements in drug formulation and delivery technologies are creating new opportunities for sugar-based excipients. The development of targeted drug delivery systems, controlled-release formulations, and personalized medicine approaches requires excipients with specific properties and functionalities. Sugar-based excipients, with their inherent biocompatibility, stability, and ability to be chemically modified, are well-suited to meet these evolving needs.Ongoing research and development efforts in the pharmaceutical industry are expected to further drive the demand for innovative sugar-based excipients. ## **Sugar Based Excipients Market Segment Insights:** ### **Sugar Based Excipients Market Type Insights** The Sugar Based Excipients Market is segmented as Type into Disintegrants, Binders, Fillers and Sweeteners. The Disintegrants segment is expected to hold the largest share in revenue in 2024 which is attributed to the increased use of orally disintegrating tablets and high usage of disintegrants in the formulation of the capsule and tablets. The Fillets segment is expected to exhibit the highest growth rate during the forecast period, which is due to the increased demand for the excipients, which have low cost and high functionality. The growth of the Sugar Based Excipients market is due to the rise in target diseases, rising geriatric population and growth in the utilization of generic drugs.The Sugar Based Excipients Market is also experiencing increased growth due to the growing demand for excipients, which are manufactured based on standard regulations and maintain the quality of the product. The Sugar Based Excipients Market is expected to grow during the forecast period and continue to grow in the upcoming years due to the increasing demand from the pharmaceutical industry. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Sugar Based Excipients Market Application Insights** The Sugar Based Excipients Market is divided by Application into Tablets, Capsules, Oral Liquids and Injectables. The Tablets segment holds the highest market share because of the easy administering and documentation process, diverse dosage forms, and cost-effectiveness. The Capsules segment follows the tablets and is preferred by formulating taste-masked, targeted, and extended-release formulations. Moreover, the Oral Liquids segment also holds a significant share because of the preference for pediatric and geriatric uses and for drugs having solubility and absorption-related issues.On the other hand, the Injectables segment, which includes vials, ampoules and prefilled syringes, is used when the drug requires rapid onset or the oral route is unacceptable. ### **Sugar Based Excipients Market Dosage Form Insights** Solid Dosage Forms, a prominent segment in the Sugar Based Excipients Market, accounted for a significant market share in 2023 and is projected to maintain its lead throughout the forecast period. Tablets and capsules are the primary dosage forms within this segment, offering advantages such as ease of administration, accurate dosing, and stability. The growing prevalence of chronic diseases and the increasing demand for oral medications contribute to the segment's growth. Liquid Dosage Forms, another important segment, is expected to witness steady growth over the forecast period.Suspensions, solutions, and syrups are common dosage forms in this segment, preferred for their rapid absorption and ease of administration, particularly for pediatric and geriatric populations. The rising demand for liquid medications for immediate release and taste-masking applications drives the segment's growth. Semi-solid dosage Forms, including ointments, creams and gels, are gaining traction in the Sugar Based Excipients Market. These dosage forms offer localized delivery, sustained release, and enhanced skin absorption, making them suitable for topical applications.The increasing demand for dermatological and cosmetic products is a key factor driving the growth of this segment. ### **Sugar Based Excipients Market End User Insights** The Sugar Based Excipients Market is segmented on the basis of end users into the Pharmaceutical Industry, Food and Beverage Industry, Cosmetics and Personal Care Industry. Among these segments, the Pharmaceutical Industry segment is expected to hold the largest share of the market in 2023, owing to the increasing demand for sugar-based excipients in the manufacturing of pharmaceutical products. The Food and Beverage Industry segment is expected to witness a significant growth rate during the forecast period due to the rising demand for processed foods and beverages.The Cosmetics and Personal Care Industry segment is also expected to grow at a steady pace during the forecast period, driven by the increasing popularity of natural and organic cosmetics and personal care products. ### **Sugar Based Excipients Market Regional Insights** The Sugar Based Excipients Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share in 2023 and is expected to continue its dominance over the forecast period. The growth of the North American market can be attributed to the increasing demand for sugar-based excipients in the pharmaceutical industry and the presence of major pharmaceutical companies in the region. Europe is the second-largest market for sugar based excipients and is expected to witness steady growth over the forecast period.The growth of the European market can be attributed to the increasing demand for sugar based excipients in the food and beverage industry and the presence of a large number of food and beverage companies in the region.  APAC is the third-largest market for sugar based excipients and is expected to witness the fastest growth over the forecast period. The growth of the APAC market can be attributed to the increasing demand for sugar based excipients in the pharmaceutical and food and beverage industries and the presence of a large number of pharmaceutical and food and beverage companies in the region.South America and MEA are expected to witness moderate growth over the forecast period. The growth of the South American and MEA markets can be attributed to the increasing demand for sugar based excipients in the pharmaceutical and food and beverage industries and the presence of a number of pharmaceutical and food and beverage companies in the regions. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **Sugar Based Excipients Market Key Players And Competitive Insights:** In a bid to acquire larger revenue shares, major players in the Sugar Based Excipients Market are constantly investing in research and development and expanding their product portfolio. Leading players in the Sugar Based Excipients Market are developing innovative products based on the requirements of the pharmaceutical excipients industry. The Sugar Based Excipients Market is characterized by the presence of a few large market players. The competition among the large market players in the Sugar Based Excipients Market is high. These players are selected based on their product portfolio, geographic presence, and distribution channels. Some key players in the sugar-based excipients market include Roquette Frres, Ingredion Incorporated, Cargill, Incorporated, Tate Lyle PLC and Archer Daniels Midland Company. The listed market players hold a significant share in the Sugar Based Excipients Market and have a strong global presence.  The market players are focused on providing premium quality products and services to end-users. They are expanding their product offerings, investing in research and development, and acquiring smaller players to gain a competitive edge.Cargill, Incorporated is one of the leading market players in the Sugar Based Excipients Market. The company holds a significant market share and has a strong global presence. Cargill, Incorporated offers a wide range of excipients, which includes starch, cellulose, and sugar-based binders and fillers. The company is focused on innovation and has a few proprietary technologies for the production of high-quality excipients. Cargill, Incorporated is well-equipped in terms of human resources and has a dedicated team of scientists and researchers.  The company’s R team is constantly working on developing new and improved products. Cargill, Incorporated, as a market leader, is preferred by a large number of pharmaceutical companies due to its commitment to quality and customer service.Tate Lyle PLC is another major market player in the Sugar the Sugar Based Excipients Market. The company offers a comprehensive range of excipients, which include starch, cellulose, and sugar-based binders and fillers. Tate Lyle PLC has focused on its commitment to sustainability and has invested in renewable energy sources. The company has invested in a few innovative products that cater to the changing requirements of the pharmaceutical industry. Tate Lyle has a strong history of providing excipients to the pharmaceutical industry and is preferred by many pharmaceutical companies as a preferred supplier due to the company’s commitment to quality and sustainability. ### **Key Companies in the Sugar Based Excipients Market Includes** - **[Ingredion](https://www.ingredion.com/na/en-us/company/expertise/sugar-reduction.html)** - Kerry - DFE Pharma - ADM - Cargill - Roquette - Lonza - Tate Lyle - The Dow Chemical Company - FrieslandCampina Ingredients - Ashland - BENEO - DuPont - Ingredion Incorporated ## **Sugar Based Excipients Market Industry Developments** The market growth is attributed to the increasing demand for sugar-based excipients in the pharmaceutical industry, particularly in the formulation of oral solid dosage forms such as tablets and capsules. Moreover, the growing prevalence of chronic diseases and the subsequent rise in drug development activities further contribute to market expansion. Recent advancements in sugar-based excipients, including the development of novel excipients with improved functionality and stability, are also expected to drive market growth. ## **Sugar Based Excipients Market Segmentation Insights** ### **Sugar Based Excipients Market Type Outlook** - Disintegrants - Binders - Fillers - Sweeteners ### **Sugar Based Excipients Market Application Outlook** - Tablets - Capsules - Oral Liquids - Injectables ### **Sugar Based Excipients Market Dosage Form Outlook** - Solid Dosage Forms - Liquid Dosage Forms - Semi-Solid Dosage Forms ### **Sugar Based Excipients Market End User Outlook** - Pharmaceutical Industry - Food and Beverage Industry - Cosmetics and Personal Care Industry ### **Sugar Based Excipients Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Rising Awareness of Health and Wellness The Sugar Based Excipients Market is significantly impacted by the rising awareness of health and wellness among consumers. As individuals become more informed about the ingredients in their food and medications, there is a growing demand for products that are perceived as safe and beneficial. Sugar based excipients, often derived from natural sources, align with this trend by offering functional benefits without compromising health. This shift is particularly evident in dietary supplements and functional foods, where sugar based excipients are utilized to enhance palatability and bioavailability. Market projections indicate that the dietary supplements sector is expected to reach USD 230 billion by 2027, further emphasizing the role of sugar based excipients in meeting consumer expectations within the Sugar Based Excipients Market. ### Advancements in Formulation Technologies The Sugar Based Excipients Market is poised for growth due to advancements in formulation technologies that enhance the efficacy of drug delivery systems. Innovations such as controlled release formulations and targeted delivery mechanisms are increasingly incorporating sugar based excipients to improve solubility and stability. These advancements are particularly relevant in the development of complex biologics and biosimilars, where excipient selection is critical for product performance. The market for advanced drug delivery systems is projected to reach USD 4.2 billion by 2025, with sugar based excipients playing a crucial role in this evolution. This trend underscores the importance of research and development in the Sugar Based Excipients Market, as companies strive to meet the demands of modern therapeutics. ### Regulatory Support for Natural Excipients The Sugar Based Excipients Market benefits from increasing regulatory support for natural excipients, which is shaping the landscape of pharmaceutical and food industries. Regulatory bodies are progressively endorsing the use of natural ingredients, recognizing their safety and efficacy in formulations. This support is particularly relevant as manufacturers seek to comply with stringent regulations while meeting consumer demands for clean label products. The market for natural excipients is anticipated to grow at a CAGR of 6.5% over the next five years, reflecting a shift towards sustainable practices. This regulatory environment fosters innovation and encourages investment in the Sugar Based Excipients Market, as companies adapt to evolving standards and consumer preferences. ### Increasing Demand for Pharmaceutical Products The Sugar Based Excipients Market is experiencing a notable surge in demand for pharmaceutical products, driven by the growing prevalence of chronic diseases and an aging population. As healthcare systems evolve, there is a heightened focus on developing effective drug formulations that enhance bioavailability and patient compliance. Sugar based excipients, known for their favorable properties, are increasingly utilized in oral solid dosage forms, which represent a substantial segment of the pharmaceutical market. According to recent data, The Sugar Based Excipients Market is projected to reach USD 7.5 billion by 2026, with sugar based excipients playing a pivotal role in this growth. This trend indicates a robust opportunity for manufacturers to innovate and expand their product offerings within the Sugar Based Excipients Market. ### Consumer Preference for Sweeteners in Food Products The Sugar Based Excipients Market is significantly influenced by the rising consumer preference for sweeteners in food products. As health-conscious consumers seek alternatives to artificial sweeteners, sugar based excipients are increasingly favored for their natural origins and functional benefits. This shift is particularly evident in the food and beverage sector, where sugar based excipients are utilized to enhance flavor, texture, and stability. Market analysis suggests that the food and beverage excipients segment is expected to grow at a CAGR of 5.2% through 2027, indicating a strong demand for sugar based solutions. This trend not only bolsters the Sugar Based Excipients Market but also encourages manufacturers to explore innovative applications in food formulations. ## Future Outlook The Sugar Based Excipients Market is projected to grow at a 6.38% CAGR from 2025 to 2035, driven by increasing demand for pharmaceutical formulations and advancements in excipient technology. **New opportunities:** - Development of customized sugar excipients for targeted drug delivery systems. - Expansion into emerging markets with tailored product offerings. - Investment in sustainable sourcing of sugar-based materials to enhance brand value. By 2035, the Sugar Based Excipients Market is expected to achieve robust growth and increased market share. ## Segment Insights ### By Type: Disintegrants (Largest) vs. Sweeteners (Fastest-Growing) The Sugar Based Excipients Market is predominantly influenced by disintegrants, which hold the largest share due to their essential role in pharmaceutical formulations. This segment effectively facilitates the breakdown of tablets and capsules, ensuring optimal drug delivery and absorption. Conversely, sweeteners are gaining traction, appealing particularly to the growing demand for sugar substitutes in both pharmaceutical and food applications, thereby making them a significant player in the market. Disintegrants (Dominant) vs. Sweeteners (Emerging) Disintegrants serve as a crucial component in the manufacturing of oral dosage forms, offering rapid dissolution and enhancing bioavailability. Their dominant position in the Sugar Based Excipients Market stems from their ability to significantly improve the performance of both solid and semi-solid dosage forms. Meanwhile, sweeteners are emerging as a transformative force, driven by the increasing consumer shift towards healthier alternatives and the rise of non-caloric sweetening agents. As the healthcare and wellness sectors continually evolve, sweeteners are well-positioned to capture significant market share owing to their growing application across diverse product lines, thus complementing traditional disintegrants. ### By Application: Tablets (Largest) vs. Capsules (Fastest-Growing) The Sugar Based Excipients Market is characterized by a diverse application segment, comprising Tablets, Capsules, Oral Liquids, and Injectables. Currently, Tablets hold the largest market share due to their long-standing presence in pharmaceuticals and consumer preference for solid dosage forms. This segment's dominance can be attributed to factors such as dosage accuracy, versatility, and ease of use, catering to both the adult and pediatric population effectively. In contrast, Capsules are gaining traction in the market, driven by their advantages in terms of bioavailability and patient compliance, especially among those who prefer capsule formulations over tablets or liquids. Tablets (Dominant) vs. Capsules (Emerging) Within the Sugar Based Excipients Market, Tablets are often regarded as the dominant application due to their established role in both prescription and over-the-counter products. Their formulation flexibility allows the inclusion of various sugar-based excipients, enhancing taste and stability. On the other hand, Capsules are emerging as a preferred choice for many manufacturers, particularly for drugs requiring rapid release or targeted delivery. The growth of capsules can be attributed to advancements in capsule technology and formulations, which offer better patient adherence due to their ease of swallowing and often improved taste masking capabilities. This shift indicates a dynamic market landscape where both segments cater to varying consumer preferences and therapeutic needs. ### By Dosage Form: Solid Dosage Forms (Largest) vs. Liquid Dosage Forms (Fastest-Growing) In the Sugar Based Excipients Market, the distribution among dosage forms shows Solid Dosage Forms taking the lead due to their wide applications in tablets and capsules. This segment is favored for its stability and ease of formulation, which makes it a preferred choice among pharmaceutical manufacturers. Conversely, Liquid Dosage Forms are gaining traction, largely driven by their suitability for pediatric and geriatric formulations, where ease of swallowing or dosage flexibility are critical. The semi-solid dosage forms are positioned in between, catering to niche applications like ointments and creams but remain less prominent in overall market share. Looking ahead, the growth trends indicate a significant shift toward Liquid Dosage Forms as the fastest-growing segment due to increasing consumer preference for liquid medications that offer better palatability and absorption rates. Additionally, advancements in formulation technologies are enhancing the appeal of these forms, making them more accessible. This evolving landscape is encouraged by demographic factors, including an aging population that often requires medications in liquid formats. Solid Dosage Forms, however, maintain their dominance due to ongoing demand in traditional pharmaceutical applications, balancing the market dynamics. Solid Dosage Forms (Dominant) vs. Liquid Dosage Forms (Emerging) Solid Dosage Forms hold a dominant position in the Sugar Based Excipients Market, primarily due to their versatility and the ability to incorporate a range of excipients for improved drug delivery. They are lauded for their precise dosing capabilities and stability, making them the go-to choice for many drug manufacturers. As the pharmaceutical industry continues to innovate, Solid Dosage Forms are increasingly being developed to accommodate diverse therapeutics, thereby securing their market position. Conversely, Liquid Dosage Forms are emerging with their unique advantages, including enhanced bioavailability and patient compliance. This segment is rapidly evolving, driven by demands for customizable formulations that cater to specific patient needs, particularly those requiring flexible dosing options. While Solid Dosage Forms remain vital, the rise of Liquid Dosage Forms reflects the industry's responsiveness to user-centric pharmaceutical solutions. ### By End User: Pharmaceutical Industry (Largest) vs. Food and Beverage Industry (Fastest-Growing) The Sugar Based Excipients Market is predominantly driven by significant demand from the pharmaceutical industry. This sector holds the largest share, utilizing sugar excipients for various applications including drug formulation and delivery systems. In comparison, the food and beverage industry is increasingly adopting these excipients, leading to rapid expansion as manufacturers seek to enhance product performance and consumer appeal. Pharmaceutical Industry (Dominant) vs. Food and Beverage Industry (Emerging) The pharmaceutical industry remains the dominant force within the Sugar Based Excipients Market due to its reliance on sugar-derived components for effective drug formulation. This sector prioritizes function and consistency in excipients to ensure optimal therapeutic effects. Meanwhile, the food and beverage industry is an emerging player, characterized by its innovative use of sugar-based excipients to improve taste, texture, and shelf-life of products. With rising health consciousness among consumers, this segment is transforming, focusing on cleaner labels and functional foods, making it a dynamic area of growth that could reshape market dynamics. ## Regional Market Share Analysis ### North America : Market Leader in Excipients North America is the largest market for sugar-based excipients, holding approximately 40% of the global market share. The region's growth is driven by increasing demand for pharmaceutical formulations and the rising prevalence of chronic diseases. Regulatory support from agencies like the FDA further catalyzes innovation and product development in this sector. The trend towards natural and organic ingredients is also influencing market dynamics, pushing manufacturers to adapt to consumer preferences. The United States is the leading country in this region, with major players such as Ashland Global Holdings Inc. and Cargill Inc. dominating the market. The competitive landscape is characterized by significant investments in R&D and strategic partnerships among key players. Canada also plays a vital role, contributing to the overall growth with its robust pharmaceutical industry and increasing focus on health and wellness products. The presence of established companies ensures a steady supply of innovative excipients to meet market demands. ### Europe : Regulatory Framework and Growth Europe is the second-largest market for sugar-based excipients, accounting for approximately 30% of the global market share. The region benefits from stringent regulatory frameworks that ensure product safety and efficacy, which in turn boosts consumer confidence. The increasing demand for biopharmaceuticals and the trend towards personalized medicine are significant growth drivers. Additionally, the European Medicines Agency (EMA) plays a crucial role in facilitating innovation through clear guidelines and support for new product development. Germany and France are the leading countries in this market, with a strong presence of key players like BASF SE and Roquette Freres. The competitive landscape is marked by a focus on sustainability and the development of innovative excipients that cater to the evolving needs of the pharmaceutical industry. Collaborations between academia and industry are also prevalent, fostering a culture of innovation and ensuring that Europe remains at the forefront of excipient development. ### Asia-Pacific : Emerging Market Potential Asia-Pacific is an emerging powerhouse in the sugar-based excipients market, holding approximately 20% of the global market share. The region's growth is fueled by increasing healthcare expenditures, a growing population, and rising awareness of health and wellness. Countries like India and China are witnessing a surge in pharmaceutical manufacturing, supported by favorable government policies and investments in healthcare infrastructure. The demand for sugar-based excipients is expected to rise as the region shifts towards more advanced pharmaceutical formulations. China is the largest market in this region, followed closely by India, where local manufacturers are increasingly focusing on quality and compliance with international standards. The competitive landscape is evolving, with both multinational corporations and local players vying for market share. Key players such as DuPont de Nemours Inc. and FMC Corporation are expanding their operations in the region, further driving growth and innovation in sugar-based excipients. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa represent a resource-rich frontier for the sugar-based excipients market, holding approximately 10% of the global market share. The region is characterized by a growing pharmaceutical sector, driven by increasing investments in healthcare and rising demand for quality medicines. Regulatory bodies are gradually enhancing their frameworks to support the pharmaceutical industry, which is expected to catalyze market growth. The demand for sugar-based excipients is anticipated to rise as local manufacturers seek to improve product quality and meet international standards. South Africa and the UAE are the leading countries in this region, with a burgeoning pharmaceutical industry and increasing focus on research and development. The competitive landscape is marked by a mix of local and international players, with companies looking to establish a foothold in this emerging market. The presence of key players is essential for driving innovation and ensuring a steady supply of excipients to meet the growing demand. ## Competitive Benchmarking The Sugar Based Excipients Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for pharmaceutical formulations and the growing trend towards natural ingredients. Key players such as Roquette Freres (FR), Ashland Global Holdings Inc. (US), and BASF SE (DE) are strategically positioning themselves through innovation and regional expansion. Roquette Freres (FR) focuses on enhancing its product portfolio with new sugar-based excipients that cater to the evolving needs of the pharmaceutical industry, while Ashland Global Holdings Inc. (US) emphasizes partnerships with local manufacturers to optimize supply chains and improve market reach. BASF SE (DE) is investing in digital transformation initiatives to streamline operations and enhance customer engagement, collectively shaping a competitive environment that prioritizes innovation and responsiveness to market demands. The business tactics employed by these companies include localizing manufacturing to reduce lead times and enhance supply chain efficiency. The Sugar Based Excipients Market appears to be moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they leverage their resources and expertise to establish a competitive edge. This competitive structure suggests that while there is room for smaller players, the dominance of established firms is likely to shape market trends and consumer preferences. In August 2025, Roquette Freres (FR) announced the launch of a new line of sugar-based excipients designed specifically for [oral solid dosage](https://www.marketresearchfuture.com/reports/oral-solid-dosage-pharmaceutical-market-24531) forms. This strategic move is expected to enhance their market position by addressing the growing demand for high-quality excipients that improve drug solubility and bioavailability. The introduction of these products aligns with the industry's shift towards more effective and patient-friendly formulations, indicating Roquette's commitment to innovation in the excipient space. In September 2025, Ashland Global Holdings Inc. (US) entered into a strategic partnership with a leading biotechnology firm to co-develop sugar-based excipients tailored for biologics. This collaboration is likely to enhance Ashland's capabilities in the rapidly expanding biologics market, allowing them to offer specialized solutions that meet the unique requirements of biologic drug formulations. Such partnerships reflect a broader trend in the industry, where collaboration is becoming essential for driving innovation and meeting complex regulatory standards. In July 2025, BASF SE (DE) unveiled a new digital platform aimed at optimizing the supply chain for its sugar-based excipients. This initiative is indicative of the company's focus on digitalization, which is increasingly becoming a critical factor in maintaining competitive advantage. By leveraging technology to enhance operational efficiency and customer service, BASF is positioning itself as a forward-thinking leader in the market, capable of responding swiftly to changing customer needs. As of October 2025, the competitive trends in the Sugar Based Excipients Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are playing a pivotal role in shaping the current landscape, as companies seek to pool resources and expertise to drive innovation. Looking ahead, it is anticipated that competitive differentiation will increasingly hinge on factors such as technological advancement, sustainable practices, and the reliability of supply chains, rather than solely on price. This shift underscores the importance of innovation and adaptability in a rapidly evolving market. ## Recent News & Developments The market growth is attributed to the increasing demand for sugar-based excipients in the pharmaceutical industry, particularly in the formulation of oral solid dosage forms such as tablets and capsules. Moreover, the growing prevalence of chronic diseases and the subsequent rise in drug development activities further contribute to market expansion. Recent advancements in sugar-based excipients, including the development of novel excipients with improved functionality and stability, are also expected to drive market growth. ## Report Scope | MARKET SIZE 2024 | 1.29(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 1.372(USD Billion) | | MARKET SIZE 2035 | 2.548(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.38% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Roquette Freres (FR), Ashland Global Holdings Inc. (US), BASF SE (DE), DuPont de Nemours Inc. (US), MannKind Corporation (US), DOW Chemical Company (US), Cargill Inc. (US), FMC Corporation (US) | | Segments Covered | Types, Applications, Dosage Form, End Users, Regional | | Key Market Opportunities | Growing demand for natural and clean-label products drives innovation in the Sugar Based Excipients Market. | | Key Market Dynamics | Rising demand for sugar based excipients driven by advancements in pharmaceutical formulations and consumer preference for natural ingredients. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Sugar Based Excipients Market?** A: The Sugar Based Excipients Market was valued at 1.29 USD Billion in 2024. **Q: What is the projected market size for the Sugar Based Excipients Market by 2035?** A: The market is projected to reach 2.548 USD Billion by 2035. **Q: What is the expected CAGR for the Sugar Based Excipients Market during the forecast period?** A: The expected CAGR for the Sugar Based Excipients Market from 2025 to 2035 is 6.38%. **Q: Which segments are included in the Sugar Based Excipients Market?** A: The market includes segments such as Disintegrants, Binders, Fillers, and Sweeteners. **Q: How do the revenue figures for Disintegrants and Binders compare in 2025?** A: In 2025, both Disintegrants and Binders are projected to generate revenues of approximately 0.785 USD Billion. **Q: What applications are driving the Sugar Based Excipients Market?** A: Key applications include Tablets, Capsules, Oral Liquids, and Injectables. **Q: What is the projected revenue for the Tablets application by 2035?** A: The Tablets application is expected to generate around 0.9 USD Billion by 2035. **Q: Which end-user industries are contributing to the Sugar Based Excipients Market?** A: The Pharmaceutical, Food and Beverage, and Cosmetics and Personal Care industries are the primary end users. **Q: What is the expected revenue for the Food and Beverage industry segment by 2035?** A: The Food and Beverage industry segment is projected to reach approximately 0.9 USD Billion by 2035. **Q: Who are the key players in the Sugar Based Excipients Market?** A: Key players include Roquette Freres, Ashland Global Holdings Inc., BASF SE, and DuPont de Nemours Inc. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/sugar-based-excipients-market-27451*